Related Experiment Video
Updated: Mar 15, 2026

05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.6K
Hashimoto's Encephalopathy Presenting with Chorea
Abhijeet Sharan1, Sarbani Sengupta2, Sarmishtha Mukhopadhyay3
1Postgraduate Trainee.
The Journal of the Association of Physicians of India
|September 10, 2016
Summary
Hashimoto's encephalopathy, a rare neurological disorder, can cause behavioral changes and involuntary movements. Prompt steroid treatment significantly improved symptoms in a patient with high antithyroid antibody levels.
Area of Science:
- Neurology
- Immunology
- Endocrinology
Background:
- Hashimoto's encephalopathy (HE) is a rare neurological condition characterized by steroid-responsive neuropsychiatric symptoms.
- It is often associated with elevated antithyroid antibodies, irrespective of thyroid function.
- Differential diagnosis involves excluding various causes of encephalopathy, including vascular, infectious, metabolic, autoimmune, paraneoplastic, and toxic etiologies.
Observation:
- A 78-year-old female presented with acute behavioral abnormalities and choreiform movements of the extremities.
- Extensive investigations ruled out other potential causes of encephalopathy.
- High titers of anti-thyroid peroxidase (anti-TPO) antibodies were detected.
Findings:
- The patient was diagnosed with Hashimoto's encephalopathy based on clinical presentation and serological findings.
- Treatment with high-dose corticosteroids resulted in a rapid and significant improvement in her neurological and behavioral symptoms.
- The choreiform movement, a key presenting symptom, resolved following steroid administration.
Implications:
- This case highlights the importance of considering HE in the differential diagnosis of unexplained encephalopathy, particularly in the presence of high antithyroid antibodies.
- Early recognition and prompt immunosuppressive therapy, such as high-dose steroids, can lead to favorable outcomes.
- Further research into the pathogenesis of HE and its specific antibody targets may refine diagnostic and therapeutic strategies.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Myasthenia Gravis: Diagnostic Tests
3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Anticholinesterase Agents: Poisoning and Treatment
1.9K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K

